Skip to content

Clinical trials

Atherosclerosis trials in Russia with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Unknown status Country / region: Russia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20131
20191
20204
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Meshalkin Research Institute of Pathology of Circulation4
Institute for Atherosclerosis Research, Russia2
AtheroNova Inc.1
Center for Strategic Planning, of the Federal Medical and Biological Agency1
Central Clinical Hospital of the Russian Academy of Sciences1
Federal State Budgetary Scientific Institution1
Ryazan State Medical University1
St. Petersburg State Pavlov Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis12
Inflammation3
Peripheral Arterial Disease3
Carotid Artery Diseases2
Coronary Artery Disease2
Acquired Immunodeficiency Syndrome1
Angina, Stable1
Atrial Fibrillation1
Cardiovascular Diseases1
Carotid Stenosis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.